Tema Heart & Health ETF (NASDAQ:HRTS) Short Interest Up 151.2% in April

Tema Heart & Health ETF (NASDAQ:HRTS) was the recipient of a significant growth in short interest in the month of April. As of April 30th, there was short interest totaling 1,595 shares, a growth of 151.2% from the April 15th total of 635 shares. Based on an average daily trading volume, of 3,009 shares, the days-to-cover ratio is presently 0.5 days. Currently, 0.1% of the shares of the company are short sold.

Tema Heart & Health ETF Stock Performance

Shares of NASDAQ HRTS traded down $0.37 during midday trading on Friday, reaching $33.52. The stock had a trading volume of 943 shares, compared to its average volume of 6,478. The company has a market capitalization of $49.94 million, a price-to-earnings ratio of 22.06 and a beta of 0.70. Tema Heart & Health ETF has a 12-month low of $26.78 and a 12-month high of $36.65. The stock has a 50-day moving average of $33.77 and a 200-day moving average of $34.67.

Institutional Trading of Tema Heart & Health ETF

Several institutional investors and hedge funds have recently added to or reduced their stakes in HRTS. Kestra Advisory Services LLC purchased a new position in Tema Heart & Health ETF in the 4th quarter worth approximately $27,000. JPMorgan Chase & Co. purchased a new stake in Tema Heart & Health ETF during the 2nd quarter valued at approximately $63,000. Jane Street Group LLC raised its position in shares of Tema Heart & Health ETF by 9.4% during the second quarter. Jane Street Group LLC now owns 37,164 shares of the company’s stock valued at $1,062,000 after buying an additional 3,202 shares during the last quarter. Stifel Financial Corp lifted its holdings in shares of Tema Heart & Health ETF by 19.8% in the fourth quarter. Stifel Financial Corp now owns 33,647 shares of the company’s stock worth $1,187,000 after buying an additional 5,571 shares in the last quarter. Finally, Citadel Advisors LLC purchased a new position in shares of Tema Heart & Health ETF in the third quarter worth $243,000.

About Tema Heart & Health ETF

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.